Short description
Artivion is a biological medical device company, which has been focused on the development of implantable biological.
Description
CryoLife, is a biological medical device company, which has been focused on the development of implantable biological devices, surgical adhesives, and biomaterials for use in cardiac and vascular reconstruction for patients for all ages. The Company preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular transplant applications. The human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using its SynerGraft technology. CryoLife's medical devices consist primarily of surgical adhesives, sealants, and hemostats, including BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), PerClot and HemoStase. In October of 2010, the Company began distributing PerClot for Starch Medical, Inc. (SMI). In May 2011, it acquired Cardiogenesis Corporation.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Kennesaw, Georgia, United States, North America
Founded on
January 1, 1984
Exited on
January 24, 2022
Went public on
January 24, 2022
Stock symbol
AORT
Non-profit?
No
Acquired?
No
Employees count
501-1000
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccessforu
Sign in for full access
Founders
Steven G. Anderson
Funding rounds count
3
Portfolio organisations count
Noway Youcantaccess, Absolutely Noaccess
Sign in for full access
Lead investments count
3